Monday, October 19 2026

Citi Pharma receives CCP nod to acquire Pakheim International
Citi Pharma Limited (CPHL) has received regulatory approval for its proposed acquisition of Pakheim International Pharma (Private) Limited. The company disclosed the development in a filing to the Pakistan Stock Exchange on Monday. “CPHL hereby informs its shareholders and the general public that the company has received the order dated October 9, 2026, passed by the Competition Commission of Pakistan (CCP) in Case No. 1614/Merger-CCP/2026, authorising the proposed acquisition of 100% shareholding of Pakheim International Pharma (Private) Limited under Section 31(1)(d)(i) of the Competition Act, 2010,” read the notice.
Related news categories: business economic-indicators pharma psx stock-exchanges
Related symbols: cphl (news stock)